Rocket

Neutron

Mars

<h3 id="key-takeaways">Key Takeaways</h3>
<ul>
 <li>Over the past year, RKLB stock has surged 43.7%, significantly outperforming competitors in the aerospace sector.</li>
 <li>ARK Investment Management, led by Cathie Wood, accumulated more than 705,000 shares of RKLB valued at approximately $44 million during two recent trading sessions.</li>
 <li>CEO Peter Beck acknowledges the year-end launch window for Neutron is “narrowing,” positioning it as both a critical opportunity and substantial risk factor.</li>
 <li>Blue Origin secured a $700 million contract from NASA for Mars communications infrastructure, representing a setback for Rocket Lab’s competitive positioning.</li>
 <li>The company’s contract backlog reached an all-time high of $2.36 billion, representing 137% growth year-over-year and ensuring solid revenue visibility.</li>
</ul>
Shares of Rocket Lab (RKLB) are currently hovering around $62.54, experiencing a 2.2% decline on Tuesday and representing more than a 50% retreat from the peak achieved in May. Nevertheless, ARK Investment Management has maintained an aggressive accumulation strategy, acquiring 705,102 shares during two recent trading sessions totaling approximately $44 million in value.
<a href="https://knockoutstocks.com/stock/RKLB" rel="noopener noreferrer nofollow"> <img src="https://knockoutstocks.com/api/stocks/RKLB/embed" alt="RKLB Stock Card"> Rocket Lab USA, Inc., RKLB </a>
The Tuesday session alone saw ARK purchase 504,799 shares distributed across three separate ETFs, representing roughly $31.6 million based on Tuesday’s closing prices.
This accumulation activity occurs against a backdrop of significant selling pressure, with RKLB declining in nine out of the last ten trading sessions, followed by additional weakness in after-hours trading.
Analyst sentiment remains constructive despite recent price target adjustments. Bank of America analyst Ronald Epstein reduced his price target from $115 to $110 on August 31, primarily accounting for anticipated share dilution, while maintaining his Buy recommendation. Even with this adjustment, Tuesday’s closing price suggests potential upside of approximately 76%.
Following the company’s second-quarter earnings release, Cantor Fitzgerald analyst Andres Sheppard raised his price target from $96 to $122, emphasizing Neutron as “the most material catalyst.” Meanwhile, Roth Capital’s Suji Desilva lowered his target from $130 to $110 while preserving his Buy rating, highlighting that the substantial backlog provides “meaningful near-term revenue coverage.”
<h3 id="the-neutron-factor">The Neutron Factor</h3>
<a href="https://knockoutstocks.com/stock/RKLB" rel="noopener noreferrer nofollow">Rocket Lab’s</a> Neutron launch vehicle represents the focal point of investor debate. The platform is designed to penetrate the medium-lift launch segment, substantially expanding the company’s addressable market beyond Electron’s small-satellite niche.
However, CEO Peter Beck cautioned during the Q2 earnings call that the timeframe for achieving an inaugural launch before year-end is “narrowing.” Critical testing phases must still be completed successfully before flight operations commence. Any additional delays to Neutron’s deployment would postpone the growth trajectory that forms the foundation of bullish analyst price targets.
The orbital launch industry continues facing supply constraints, positioning Rocket Lab favorably if operational execution remains on track. Electron has successfully completed 87 missions to date, while HASTE provides critical support for government programs. The company currently has commitments for over 90 launches spanning Electron, HASTE, and Neutron platforms.
<h3 id="nasa-contract-loss-and-backlog-strength">NASA Contract Loss and Backlog Strength</h3>
Market sentiment experienced another setback in after-hours trading Tuesday when NASA announced Blue Origin as the recipient of its Mars Telecommunications Network contract. This firm-fixed-price agreement carries a potential value of $700 million, with Blue Origin responsible for deploying a Mars orbiter by late 2028. Rocket Lab had been among the eligible bidders for this opportunity.
Despite this disappointment, the company’s Q2 2026 backlog achieved a record $2.36 billion, representing 137% growth compared to the prior year. Approximately 45.5% of this contracted work is scheduled for revenue recognition within the next twelve months.
Recent strategic acquisitions of Mynaric and Motiv have enhanced Rocket Lab’s capabilities in optical communications and robotics technologies. In August 2026, the company secured a position on the U.S. Space Force’s NITE-STAR IDIQ program, a contracting vehicle with a $981 million ceiling encompassing both space-based and ground systems.
Wall Street’s consensus earnings per share estimate for RKLB in 2026 has increased 44.44% during the past 60 days. The company maintains a total debt to capital ratio of just 0.83%, significantly below the industry benchmark of 61.47%. Its current ratio stands at 5.48, compared to the industry average of 2.06.
RKLB currently commands a valuation of 31.3X forward Price/Sales, representing a substantial premium compared to the industry average of 7.64X.
The post <a href="https://blockonomi.com/rocket-lab-rklb-stock-should-you-follow-cathie-woods-44m-buying-spree/" rel="noopener noreferrer nofollow">Rocket Lab (RKLB) Stock: Should You Follow Cathie Wood’s $44M Buying Spree?</a> appeared first on <a href="https://blockonomi.com" rel="noopener noreferrer nofollow">Blockonomi</a>.

Rocket Lab (RKLB) Stock: Should You Follow Cathie Wood’s $44M Buying Spree?

Table of Contents

Blockonomi

Other articles published on Sep 2, 2026

Join our free newsletter for daily crypto updates!